(1,3)-β-D-Glucan is a component of the cell walls of many fungal organisms. Scientists investigate the feasibility of the BG assay and its contribution to early diagnosis of different types of inva...
Genobio Successfully Approved by Health Canada for its Aspergillus Rapid Test
Tianjin, China – September 14, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, ...
Meeting Era Biology at ECCMID 2023
The ECCMID congress, the Annual Congress of Clinical Microbiology and Infectious Diseases, is one of the most important events in the field of clinical microbiolo...
C. auris, first identified in 2009 in Asia, has quickly become a cause of severe infections around the world. C. auris is a concerning drug-resistant fungus. It can cause outbreak in healthcare fa...
Day 2 at ISHAM 2022
New Delhi, India – September 21, 2022 – Genobio with Indian local Partner Bio-State is participating 21th congress of the International Society for Human and Animal Mycology (IS...
On June 7th, Era Biology hosted a live webinar for Latin America. The webinar focuses on antimicrobial resistance problem. Since 2005, the antibiotic resistance rate of bacteria has been increasing...